ANXITANEReg. tablets reduce fear of human beings in a laboratory model of anxiety-related behavior.

摘要

Anxiety and fear are common underlying factors in many canine behavior problems that impair the human-pet bond and often result in abandonment, relinquishment, or euthanasia. A combination of behavioral and pharmacological interventions is used to ameliorate the behavioral signs associated with anxiety-related behaviors in dogs, but there continues to be need for effective interventions. The current study examined the effects of the nutraceutical ANXITANEReg. (L-Theanine) chewable tablets on fear of unfamiliar human beings. We first characterized dogs as anxious on the basis of the existence of a fear response to human beings in their home-pen. We then demonstrated that dogs characterized as anxious (N=10) showed reduced interaction with an unknown human being as compared with normal controls (N=7). The effect of an administration of ANXITANEReg. tablets (N=5) on these anxious Beagle dogs was compared with placebo (N=5). Objective behavioral measures of anxiety were obtained using an open-field test, a human interaction test, and an actiwatch protocol that allowed monitoring of activity over 24-hours. The ANXITANEReg. tablets-treated dogs showed greater human interaction and approach than the placebo control group, and no side effects related to treatment, including motor stimulant or sedative effects, were seen. The current study suggests that ANXITANEReg. tablets are effective for reducing fearful behavior toward unfamiliar human beings in dogs and supports their use for treating anxiety-related behaviors.